Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DK:NOVO/B
Recent news which mentions DK:NOVO/B
LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs
December 13, 2023
Tickers
LFMD
LLY
MED
NVO
Tags
LFMD
NVO
LLY
From
MarketWatch
Walmart seems to have changed its view of weight-loss drugs
December 06, 2023
Tickers
GIS
K
KO
LLY
Tags
WMT
K
DK:NOVO/B
From
MarketWatch
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
December 04, 2023
Tickers
LLY
PFE
WMT
Tags
CH:ROG
DK:NOVO/B
LLY
From
MarketWatch
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
December 01, 2023
Tickers
LLY
NVO
PFE
SPX
Tags
DK:NOVO/B
SPX
PFE
From
MarketWatch
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
November 22, 2023
Tickers
AMGN
ARKK
BFIT
COMP
Tags
LLY
AMGN
VRTX
From
MarketWatch
Hedge funds plow cash into top tech stocks leading to record levels of crowding
November 21, 2023
Tickers
AAPL
ABT
AMZN
GOOG
Tags
GOOG
AMZN
ABT
From
MarketWatch
British Land leads U.K. real estate stocks higher amid optimism on rents
November 13, 2023
Tags
UK:SGRO
DK:NOVO/B
UK:LAND
From
MarketWatch
Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies
November 02, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
DK:NOVO/B
From
MarketWatch
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
October 31, 2023
Tickers
ABBV
AMGN
LLY
NVO
Tags
NVO
LLY
AMGN
From
MarketWatch
Who is having the most influence over your money in 2023? Meet the MarketWatch 50.
October 31, 2023
Tickers
AAPL
AMZN
BRK-B
DVA
Tags
AAPL
PEP
UAL
From
MarketWatch
The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
October 24, 2023
Tickers
A
AAPL
AMC
AVTR
Tags
LLY
KO
NVO
From
MarketWatch
Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three
October 17, 2023
Tickers
ACWX
ASML
FERG
HDB
Tags
WMT
HDB
JP:7741
From
MarketWatch
What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.
October 13, 2023
Tickers
CPB
GIS
HSY
K
Tags
DK:NOVO/B
CPB
MDLZ
From
MarketWatch
DaVita plays down Ozempic’s potential in treating kidney disease
October 12, 2023
Tickers
DVA
SPX
Tags
DVA
SPX
DK:NOVO/B
From
MarketWatch
LVMH shares slump on sales miss, sending rival luxury-goods makers lower
October 11, 2023
Tags
HK:1913
FR:RMS
UK:BP
From
MarketWatch
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
October 11, 2023
Tickers
FMS
LLY
NVS
Tags
XE:FRE
LLY
DK:NOVO/B
From
MarketWatch
Coca-Cola and PepsiCo’s stocks fall after Walmart says weight-loss drugs have customers cutting back on calories
October 06, 2023
Tickers
LLY
NVO
PEP
SPX
Tags
DK:NOVO/B
NVO
PEP
From
MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
Tickers
ABBV
ABT
AKRO
ETNB
Tags
MDGL
UNH
FR:SAN
From
MarketWatch
Novo Nordisk, now Europe’s second-largest company by market cap, lifts outlook after 46% profit rise
August 10, 2023
Tickers
NVO
Tags
DK:NOVO/B
NVO
From
MarketWatch
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
August 09, 2023
Tickers
LLY
NVO
SPX
VKTX
Tags
DK:NOVO/B
NVO
XBI
From
MarketWatch
As obesity drugs help people eat less, these food companies could be the biggest losers
August 08, 2023
Tickers
ACI
BJ
BRBR
CAVA
Tags
WMT
KO
LLY
From
MarketWatch
Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
August 08, 2023
Tickers
DJIA
JNJ
LLY
MRK
Tags
DK:NOVO/B
DJIA
MRK
From
MarketWatch
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
August 08, 2023
Tickers
LLY
NVO
PFE
Tags
DK:NOVO/B
PFE
LLY
From
MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
July 21, 2023
Tickers
ALT
CTLT
GPCR
LLY
Tags
CTLT
DK:NOVO/B
XE:GXI
From
MarketWatch
EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm
July 11, 2023
Tickers
LLY
PFE
Tags
DK:NOVO/B
LLY
PFE
From
MarketWatch
Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
June 29, 2023
Tickers
LLY
PFE
RAD
Tags
PFE
LLY
DK:NOVO/B
From
MarketWatch
Student-loan payments are coming back — and these are the stocks most at risk
June 20, 2023
Tickers
AAPL
AEO
AMC
BABA
Tags
EYE
FDX
NIO
From
MarketWatch
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
June 20, 2023
Tickers
LLY
NVO
Tags
DK:NOVO/B
LLY
NVO
From
MarketWatch
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
February 13, 2023
Tickers
ETNB
GNFT
ICPT
LLY
Tags
DK:NOVO/B
GNFT
VKTX
From
MarketWatch
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
February 02, 2023
Tickers
LLY
SPX
Tags
LLY
DK:NOVO/B
SPX
From
MarketWatch
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.